Africa Diabetes

• Nigeria Neuropathic Pain Management Drugs Market, by Drug Class (Anticonvulsants, Serotonin–norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Others), by Disease Condition (Diabetic Neuropathy, Chemotherapy-induced Peripheral Neuropathy, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  Feb 09, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Neuropathic pain is a complex, long-term pain condition that is frequently accompanied by tissue damage. It may ... Read More

• SOUTH AFRICA DIABETES DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)

  Jan 17, 2022  |  Published by: Mordor Intelligence Inc  |  USD 4,750

  ... is expected to grow at a CAGR of 4.5% during the forecast period (2021 - 2026). In South Africa, diabetes care devices are being used effectively for the management and monitoring of blood glucose levels ... Read More

< prev 1 2 3 next >